Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Thermo Fisher ScientificBSP:TMOS34 -1.22%77 3-Year Book Growth Rate is 8.00% as of Jun. 2026, which is 29% below its 10-year median of 11.20. GuruFocus rates BSP:TMOS34 with a GF Score™ of 77/100 and a GF Value™ of R$64.40 (Fairly Valued). The stock has 10 warning signs investors should review. Among 192 Medical Diagnostics & Research companies, Thermo Fisher Scientific ranks better than 73.96% on this metric.
During the past 12 months, Thermo Fisher Scientific's average Book Value per Share Growth Rate was 6.50% per year.
During the past 3 years, the average Book Value per Share Growth Rate was 8.00% per year.
During the past 5 years, the average Book Value per Share Growth Rate was 9.60% per year.
During the past 10 years, the average Book Value per Share Growth Rate was 11.10% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.
During the past 13 years, the highest 3-Year average Book Value per Share Growth Rate of Thermo Fisher Scientific was 32.30% per year. The lowest was -8.70% per year. And the median was 11.20% per year.
Thermo Fisher Scientific (BSP:TMOS34) 3-Year Book Growth Rate Explanation
Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.
Thermo Fisher Scientific 3-Year Book Growth Rate Related Terms
BSP:TMOS34 vs DHR, IDXX, A: 3-Year Book Growth Rate Comparison
For the Diagnostics & Research subindustry, Thermo Fisher Scientific's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Thermo Fisher Scientific 3-Year Book Growth Rate vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Thermo Fisher Scientific's 3-Year Book Growth Rate distribution charts can be found below:
* The bar in red indicates where Thermo Fisher Scientific's 3-Year Book Growth Rate falls into.
Thermo Fisher Scientific 3-Year Book Growth Rate Calculation
This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.
What does a 3-Year Book Growth Rate of 8.00% mean?
Thermo Fisher Scientific (BSP:TMOS34) has a 3-Year Book Growth Rate of 8.00% as of Jun. 2026. 3-Year Book Growth Rate is the 3-year average growth rate of Book Value per Share. View historical data for Thermo Fisher Scientific and its competitors. This is 29% below median its historical median of 11.20. According to the industry distribution chart, Thermo Fisher Scientific ranks #50 out of 192 companies in the Medical Diagnostics & Research industry, placing it in the top 26%.
Is Thermo Fisher Scientific's 3-Year Book Growth Rate too high?
Thermo Fisher Scientific's current 3-Year Book Growth Rate of 8.00% is 29% below median its 10-year median of 11.20. Based on the distribution chart, Thermo Fisher Scientific ranks #50 out of 192 companies in the Medical Diagnostics & Research industry, which is above the industry midpoint. Overall, Thermo Fisher Scientific has a GF Score™ of 77/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Thermo Fisher Scientific's 3-Year Book Growth Rate compare to DHR and IDXX?
According to the Medical Diagnostics & Research industry distribution chart, Thermo Fisher Scientific ranks #50 out of 192 companies for 3-Year Book Growth Rate. This puts Thermo Fisher Scientific in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year Book Growth Rate for a Medical Diagnostics & Research company?
A good 3-Year Book Growth Rate depends on the Medical Diagnostics & Research industry context. However, 3-Year Book Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year Book Growth Rate mean?
A high 3-Year Book Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year Book Growth Rate is the 3-year average growth rate of Book Value per Share. View historical data for Thermo Fisher Scientific and its competitors. Thermo Fisher Scientific's current 3-Year Book Growth Rate is 8.00%, which is 29% below median its own 10-year median of 11.20. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Thermo Fisher Scientific stock overvalued right now?
Based on GuruFocus' analysis, Thermo Fisher Scientific (BSP:TMOS34) is currently considered Fairly Valued. The stock's GF Value™ is R$64.40, compared to a current price of R$67.20 — trading 4.3% above its estimated fair value. The current 3-Year Book Growth Rate is 8.00%, which is 29% below median its 10-year median of 11.20. Thermo Fisher Scientific's overall GF Score™ is 77/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year Book Growth Rate calculated?
3-Year Book Growth Rate is calculated from a company's financial statements. For Thermo Fisher Scientific (BSP:TMOS34), the current 3-Year Book Growth Rate is 8.00% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Thermo Fisher Scientific (BSP:TMOS34) Overvalued in 2026?
Based on GuruFocus' analysis, Thermo Fisher Scientific stock appears to be overvalued.
The current stock price of R$67.20 is trading 4.3% above its estimated GF Value™ of R$64.40.
GuruFocus considers Thermo Fisher Scientific to be Fairly Valued.
Key valuation signals for BSP:TMOS34:
3-Year Book Growth Rate: 8.00% (29% below median its 10-year median of 11.20)
GF Value™: R$64.40 vs. price of R$67.20 (4.3% above fair value)
No single metric tells the full story. See the BSP:TMOS34 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of year-end 2025 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (23%); and lab products and services, which includes CRO services (the remainder).
77GF Score
Get the complete analysis for BSP:TMOS34
3-Year Book Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BSP:TMOS34 has been successfully added to your 
